免疫效应细胞相关的血细胞淋巴细胞类似综合征 (IEC-HS)
Jerry C Lee1, William T Johnson2, Melissa Hines3
1Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California, UCSF Box 0345, 400 Parnassus Avenue, San Francisco, CA 94143, USA.
Hematology/oncology clinics of North America
|March 30, 2025
概括
免疫效应细胞相关的血细胞淋巴组织细胞样综合征 (IEC-HS) 是采用细胞疗法的严重并发症. 早期识别和管理对于改善这种危及生命的疾病患者的结果至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- 免疫效应细胞相关的血细胞淋巴组织细胞样综合征 (IEC-HS) 是采用细胞疗法的并发症.
- IEC-HS呈现出高炎症,模仿初级和二级血细胞淋巴细胞瘤.
- 它是一种因T细胞介导的抗癌疗法引起的阳性性疾病.
研究的目的:
- 突出IEC-HS作为采用细胞疗法的并发症的关键性质.
- 强调需要准确的识别和有效的管理策略.
- 强调支持性护理在改善IEC-HS患者治疗结果方面的重要性.
主要方法:
- 该研究回顾了与IEC-HS相关的临床表现和实验室发现.
- 它将IEC-HS与其他相关综合征区分开来,例如细胞因子释放综合征和IEC相关的神经毒性.
- 摘要侧重于IEC-HS的认可和临床影响.
主要成果:
- IEC-HS的特征是高炎症,血清费里丁和肝转氨酶的升高,细胞数量的减少和低纤维素生成血.
- 如果不适当管理,这种综合征可能会危及生命.
- IEC-HS与其他免疫效应细胞相关的毒性不同.
结论:
- 准确识别IEC-HS对于及时干预至关重要.
- 优化治疗策略和提供支持性护理对于改善患者结果至关重要.
- IEC-HS代表了一个重要的,可能致命的并发症,需要仔细的临床治疗.
相关概念视频
Ion-Exchange Chromatography
Ion-exchange chromatography, or IEC, is a technique for separating ions based on their affinity for the stationary phase. The stationary phase is a cross-linked polymer resin with covalently attached ionic functional groups. The functional groups can be either positively charged (cation exchangers) or negatively charged (anion exchangers). A cation exchanger consists of a polymeric anion and active cations, while an anion exchanger is a polymeric cation with active anions. The choice of...
Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...


